Systematic reviews on corona disease 2019 (COVID-19)
COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is very limited data available on almost all aspects of this disease.
We are refocussing our work to provide rapid systematic reviews on COVID-19. In the first place we will focus on risk factors for prognosis, risk factors for incidence and the effectiveness of new interventions.
We are looking for colleagues with experience in systematic reviews to help us, specifically those with expertise literature searching of pre-print journals and archives, critical appraisal and meta-analyses in stata.
If you are interested please contact m.zeegers@maastrichtuniversity.nl
Also read
-
17 million for Dutch mega cohort: working together to build healthier ageing
MUMC+ is main applicant in the Dutch Cohort Consortium: a unique research infrastructure with data from almost half a million Dutch citizens.
-
Letting bone and cartilage repair themselves
Tim ten Brink focuses on developing implants for damaged bone and cartilage, so eventually there is less need for invasive surgery.
-
Is prevention cheaper than cure?
Preventing disease is not always cheaper than treating it — but it can be vital for keeping healthcare affordable and accessible. Professor Mickaël Hiligsmann (VHC), newly appointed Professor of Health Preferences and Economics of Prevention at CAPHRI, studies how preventive measures can deliver...
